OWLSTONE MEDICAL
Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory disease, and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs. The company’s Breath Biopsy® platform has introduced a new diagnostic modality making it possible to discover novel non-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA Breath Sampler ensures a ... reliable collection of breath samples. The volatile organic compounds (VOCs) present in the breath are analyzed using proven microchip chemical sensor technology (FAIMS) to detect biomarkers of disease. The Breath Biopsy platform can be used in clinical diagnostics and precision medicine with applications in cancer and a wide range of other medical conditions. Highly sensitive and selective, these tests allow for early diagnosis when treatments are more effective and more lives can be saved. Owlstone Medical is currently developing tests for lung and colorectal cancer, two of the most common cancer killers worldwide, and for asthma stratification by the therapeutic response. The company also Breath Biopsy products and services to academic, clinical, and pharma partners who want to develop breath-based diagnostics for their own applications.
OWLSTONE MEDICAL
Industry:
Emergency Medicine Health Care Health Diagnostics Medical Device
Founded:
2004-05-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.owlstonemedical.com
Total Employee:
101+
Status:
Active
Contact:
+4401223428200
Total Funding:
132.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Mobile Non Scaleable Content
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Inito
Inito is the world’s first comprehensive at-home diagnostics device & App.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
NanoCellect Biomedical
NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.
Redcliffe Labs
Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.
ResApp Health
ResApp is developing digital healthcare solutions to assist doctors
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
Current Employees Featured
Founder
Investors List
Horizons Ventures
Horizons Ventures investment in Series D - Owlstone Medical
Ventura Capital
Ventura Capital investment in Venture Round - Owlstone Medical
Horizons Ventures
Horizons Ventures investment in Venture Round - Owlstone Medical
Foxconn Technology Group
Foxconn Technology Group investment in Venture Round - Owlstone Medical
Horizons Ventures
Horizons Ventures investment in Venture Round - Owlstone Medical
Aviva Ventures
Aviva Ventures investment in Venture Round - Owlstone Medical
Aviva Ventures
Aviva Ventures investment in Venture Round - Owlstone Medical
Medtekwiz Advisory Ltd
Medtekwiz Advisory Ltd investment in Venture Round - Owlstone Medical
V Ventures
V Ventures investment in Corporate Round - Owlstone Medical
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-03 | Owlstone Medical appoints Tween as CFO |
Official Site Inspections
http://www.owlstonemedical.com Semrush global rank: 2.19 M Semrush visits lastest month: 9 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Owlstone Medical"
Meet our team - owlstonemedical.com
Meet Our Team. Originally spun-out from the Engineering department at Cambridge University in 2004, Owlstone Medical now employs more than 150 engineers, chemists, biochemists, …See details»
About Owlstone Medical - #BreathBiopsy #Save100kLives
About. Owlstone Medical is developing a breathalyzer for disease. Our mission is to save 100,000 lives and $1.5B in healthcare costs by advancing early detection and precision medicine.See details»
Owlstone Medical - Crunchbase Company Profile
Owlstone Medical is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection.See details»
Owlstone Medical - Overview, News & Similar companies
Owlstone Medical contact info: Phone number: +44 1223428200 Website: www.owlstonemedical.com What does Owlstone Medical do? Owlstone Medical is a medical …See details»
Owlstone Medical
Owlstone Medical is developing a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease. Our mission is to save 100,000 lives and $1.5B in …See details»
Owlstone Medical Ltd - Cambridge Science Park
Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by developing Breath Biopsy® for applications in early detection and precision medicine across a wide range of diseases. Breath Biopsy detects …See details»
About Owlstone Medical Ltd. - Ingredients Network
Jun 23, 2023 About Company description. Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by breath-based diagnostics, through the development and …See details»
Owlstone Medical – Connect
Connect with Owlstone Medical to stay up-to-date and receive notifications about new job openingsSee details»
Meet Our Talented Team - Owlstone Medical
Leading the field of breath research. Originally spun-out from the Engineering department at Cambridge University in 2004, Owlstone Medical now employs more than 150 engineers, chemists, biochemists, medical doctors, project …See details»
Owlstone Medical - LinkedIn
Owlstone Medical | 16,037 followers on LinkedIn. On a mission to save 100k lives and $1.5B healthcare costs | Owlstone Medical is developing a breathalyzer for disease. With a goal of finding ways ...See details»
Owlstone Medical’s ReCIVA Named Invention of the Year in Top …
Www.owlstonemedical.com Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory disease and infectious disease, the …See details»
Owlstone Medical Enters into a Research Collaboration Agreement …
Sep 30, 2024 Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announcedSee details»
Owlstone Medical introduces Breath Biopsy VOC Atlas
4 days ago Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, has launched the Breath Biopsy VOC Atlas, a catalogue of …See details»
Our Mission | Owlstone Medical, home of Breath Biopsy
Cancer killed close to 10 million people in 2020 1.It is a stark reality that 1 in 2 of us will get cancer. From our parents to our partners, our children, our grandchildren – 1 in 2 will get cancer.See details»
Owlstone Medical partners with the FDA to advance the …
Sep 30, 2024 Collaboration will develop analytical methods to improve the identification of specific chemicals in complex gaseous mixtures Owlstone will use the developed methods and …See details»
Owlstone Medical | Cambridge - Facebook
Owlstone Medical, Cambridge, Cambridgeshire. 2,313 likes · 31 talking about this. Owlstone Medical is the world leader in breath analysis. Our Breath...See details»
Breath Biopsy Resources - Papers, Posters, Webinars etc
Owlstone Medical is developing a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease. Our mission is to save 100,000 lives and $1.5B in …See details»
Owlstone Medical Secures $6.5 Million to Support Development of …
Apr 25, 2024 $5 million equity investment and initial $1.5 million grant funding committed by the Bill & Melinda Gates Foundation for development of breath-based diagnostic solutions to …See details»
Owlstone Launches OMED Health for Gut Microbiome Insights
Apr 4, 2023 About Owlstone Medical (www.owlstonemedical.com): Owlstone Medical’s vision is to save 100,000 lives by realizing the enormous promise of breath-based diagnostics through …See details»